Taiwan mulls Panadol controls as mainland China’s Covid-19 surge sparks run on pain and fever drug

6256a261-43a1-4fb0-a71c-ceeba238c93b_1be42b6c

Taiwan is considering controls on bulk purchases of Panadol as a critical shortage of pain and fever drugs in mainland China spurs a buying spree on the island.

Demand for Panadol, a well-known paracetamol brand manufactured by UK-based Haleon Plc, had risen sharply in Taiwan over the past week, with many pharmacies running out, Taiwanese health authorities said.